Trial Search Results
Magnetic Resonance Imaging of Breast Cancer
To compare magnetic resonance imaging (MRI) with more well established diagnostic imaging techniques to determine which method best finds and defines breast cancer.
Stanford is currently accepting patients for this trial.
Collaborator: National Institutes of Health (NIH)
- Procedure: MRI
- Documented breast physical examination,
- Documented mammography within 3 months of the MR studies
- Palpable or mammographically-detected suspect breast lesions
- Women who have already undergone lumpectomy for breast cancer and have
post-biopsy/post-radiation changes will be eligible if they have
mammographically-detected or palpable breast abnormalities which are sufficiently
suspicious to merit core needle or surgical biopsy.
- Male by birth
- Able to complete the MR examination. Subjects will be interviewed by one of the
investigators for the usual contraindications to
- MR contraindications including
- Metallic implants
- Severe claustrophobia
- Aneurysm clips
- Current lactation
- Other conditions precluding proximity to a strong magnetic field.
- Received an enhanced MR procedure within 48 hours,
- Iodinated contrast within six hours,
- Known sensitivity to MR contrast agents,
- Not likely to complete the study in full or
- Other clinical reason which would preclude participation in the protocol.
Ages Eligible for Study
21 Years - N/A
Genders Eligible for Study